The recent analytical report published by Markntel Advisors (a leading consulting, data analytics, and market research firm), Rare Disease Testing Market comprises a detailed study of critical and major aspects of market dynamics, i.e. market trends, size, forecasts, growth factors, challenges, and competitor landscape. The research company provides an extensive range of strategic reports on diverse industry verticals to substantial and varied client bases, including multinational corporations, financial institutions, governments, and individuals, among others.
Rare Disease Testing Industry Analytical Overview (2021-2026): Drivers, Opportunities, Challenges, and Trends,
According to the latest report, Rare Disease Testing Market is anticipated to grow at a CAGR of around 9.29% during the forecast period, i.e., 2021-26. The report significantly addressed considerable changes, gap analyses, and competitive studies using qualitative and quantitative data. These include the widespread segmentation, geography, and recent developments, entailing information on the fluctuation in the demand, sales, revenue, and other parameters experienced and expected in the industry for the forecasting year i.e. 2021 to 2026.
In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Download Report Sample PDF - https://www.marknteladvisors.com/query/request-sample/rare-disease-testing-market.html
What is Included in Rare Disease Testing Market Segmentation?
The report has segmented the market into the following categories:
By Type
- Cardiovascular
- Ophthalmological
- Neurological
- Oncological
- Hematological
- Endocrine and Metabolism
- Gastroenterologist
- Others
In 2021, Neurological Disease Testing captured more than 20% of the revenue share, and its dominance would continue to prevail during 2021-26. Neurological disease testing involves assessing hearing, vision, balance, coordination, speech, sensory skills, and mental status & behavior. Laboratory screening of urine, blood, & other body fluids helps doctors test & understand disease severity and monitor levels of therapeutic drugs. Genetic testing can also be used to diagnose hereditary disorders.
By Acquisition
- Genetic
- Externally Acquired
By Technology
- Next Generation Sequencing
- Complete Genome
- Complete Exome
- Micro Arrays
- Others
By Age Group
- 0-15 yrs.
- 16-30 yrs.
- 31-45 yrs.
- Others
By Products
- Kits & Assays
- Panels
- Others
By End User
- Hospitals
- Diagnostics Laboratories
- Clinical Laboratories
- Contract Research Organizations
- Others
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia Pacific
("Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.")
Access the Complete Report for An In-Depth Analysis - https://www.marknteladvisors.com/research-library/rare-disease-testing-market.html
Key Factor Driver Rare Disease Testing Industry Growth by 2026
Rare diseases are not rare since there are more than 7000 of them, affecting 350 million people worldwide. Around 30 million people are affected by rare diseases in the U.S. About 10.00% of the world's population suffers from rare diseases. Each year, the last day of February (28th or 29th) is celebrated as World Day for Rare Diseases to increase awareness about them so that early diagnosis and treatment are possible.
Who are the Key Players Operating in the Rare Disease Testing Industry?
The top companies of the Rare Disease Testing market ruling the industry are:
- Quest Diagnostics Inc.
- Centogene N.V.
- Invitae Corporation.
- 3billion, Inc.
- Arup Laboratories.
- Eurofins Scientific.
- Strand Life Sciences.
- Ambry Genetics.
- Color Genomics, Inc.
- Health Network Laboratories
- PreventionGenetics
- Progenity, Inc.
- Myriad Genetics, Inc.
- Laboratory Corporation of America Holdings
- OPKO Health, Inc.
*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
Click Here to Connect with Our Expertise - https://www.marknteladvisors.com/query/talk-to-our-consultant/rare-disease-testing-market.html
Key Objectives of Choosing Markntel Advisor’s Report
- Focused Industry Expertise
- Diverse Report Offerings
- Personalized Research Solutions
- Robust Research Methodology
- In-depth Report Coverage
- Tracking Technological Advancements
- Comprehensive Value-Chain Analysis
- Discovering Market Opportunities
- Analysing Growth Trajectories
- Assured Quality Insights
- Dedicated After-Sales Support
FAQs (Frequently Ask Questions)
- What are the industry’s overall statistics or estimates including CARG and USD Value of the forecasting years?
- What are the trends influencing the current scenario of the Rare Disease Testing Market?
- What are the key factors that would propel and hinder the industry?
- Which geographical area dominates the Rare Disease Testing industry?
- Which is the Leading segment in the market?
About US:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
For Media Inquiries, Please Contact:
Phone: +1 628 895 8081 | +91 120 4278433
Email: [email protected]
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
